Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Receivables: 2019-2024

Historic Receivables for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $229,000.

  • Benitec Biopharma's Receivables fell 94.34% to $3,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $238,000, marking a year-over-year increase of 11.21%. This contributed to the annual value of $229,000 for FY2024, which is 316.36% up from last year.
  • As of FY2024, Benitec Biopharma's Receivables stood at $229,000, which was up 316.36% from $55,000 recorded in FY2023.
  • Benitec Biopharma's Receivables' 5-year high stood at $229,000 during FY2024, with a 5-year trough of $3,000 in FY2022.
  • Over the past 3 years, Benitec Biopharma's median Receivables value was $55,000 (recorded in 2023), while the average stood at $95,667.
  • In the last 5 years, Benitec Biopharma's Receivables slumped by 97.34% in 2020 and then soared by 1,733.33% in 2023.
  • Yearly analysis of 5 years shows Benitec Biopharma's Receivables stood at $118,000 in 2020, then plummeted by 78.81% to $25,000 in 2021, then crashed by 88.00% to $3,000 in 2022, then surged by 1,733.33% to $55,000 in 2023, then surged by 316.36% to $229,000 in 2024.